Michel Dahan - Net Worth and Insider Trading
Michel Dahan Net Worth
The estimated net worth of Michel Dahan is at least $772,906 dollars as of 2024-06-03. Michel Dahan is the SVP, COO of Akebia Therapeutics Inc and owns about 672,092 shares of Akebia Therapeutics Inc (AKBA) stock worth over $772,906. Details can be seen in Michel Dahan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michel Dahan has not made any transactions after 2024-05-13 and currently still holds the listed stock(s).
Transaction Summary of Michel Dahan
Michel Dahan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michel Dahan owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .
Click here to see the complete history of Michel Dahan’s form 4 insider trades.
Insider Ownership Summary of Michel Dahan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-05-13 | SVP & Chief Business Officer |
Michel Dahan Latest Holdings Summary
Michel Dahan currently owns a total of 1 stock. Michel Dahan owns 672,092 shares of Akebia Therapeutics Inc (AKBA) as of May 13, 2024, with a value of $772,906.
Latest Holdings of Michel Dahan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-05-13 | 672,092 | 1.15 | 772,906 |
Holding Weightings of Michel Dahan
Michel Dahan Form 4 Trading Tracker
According to the SEC Form 4 filings, Michel Dahan has made a total of 8 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 34,840 shares on May 13, 2024, which brought Michel Dahan around $43,898.
Insider Trading History of Michel Dahan
- 1
Michel Dahan Trading Performance
Michel Dahan Ownership Network
Michel Dahan Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Michel Dahan is the SVP & Chief Business Officer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & General Counsel & Sec. Nicole R. Hadas , SVP & Chief Medical Officer Steven Keith Burke , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Michel Dahan made 6 insider transaction in Akebia Therapeutics Inc (AKBA) with a net sale of 180,225. Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 127,765 shares made by Steven Keith Burke , a net sale of 108,298 shares made by Nicole R. Hadas , and a net sale of 214,803 shares made by John P. Butler .
In summary, during the past 3 months, insiders sold 46,856 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 46,856 shares. During the past 18 months, 709,407 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 709,407 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Michel Dahan Mailing Address
Above is the net worth, insider trading, and ownership report for Michel Dahan. You might contact Michel Dahan via mailing address: C/o Akebia Therapeutics, Inc., 245 First Street, Suite 1100, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
